Perspective Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q2 2011 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Perspective Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q2 2011 to Q2 2024.
  • Perspective Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 67.4M shares, a 76% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 67.4M -213M -76% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 587M +308M +111% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 28.2M -114M -80.2% Dec 31, 2023 10-Q 2024-08-13
Q3 2023 281M +138M +97.4% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 280M +138M +97.5% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 279M +137M +96.2% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 142M +72.5K +0.05% Dec 31, 2022 10-K 2024-03-28
Q3 2022 142M +198K +0.14% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 142M +125K +0.09% Jun 30, 2022 10-KT 2023-05-01
Q1 2022 142M +575K +0.41% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 142M +54.8M +62.8% Dec 31, 2021 10-Q 2022-02-09
Q3 2021 142M +73M +106% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 142M +73M +106% Jun 30, 2021 10-KT 2023-05-01
Q1 2021 141M +73.8M +109% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 87.2M +19.8M +29.4% Dec 31, 2020 10-Q 2021-02-09
Q3 2020 68.9M +1.51M +2.24% Sep 30, 2020 10-Q 2020-11-13
Q2 2020 68.9M +1.51M +2.24% Jun 30, 2020 10-K 2021-09-27
Q1 2020 67.7M +313K +0.46% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 67.4M +56.9K +0.09% Dec 31, 2019 10-Q 2020-02-12
Q3 2019 67.4M +56.9K +0.09% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 67.4M +11.1M +19.6% Jun 30, 2019 10-K 2020-09-25
Q1 2019 67.3M +12.2M +22.2% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 67.3M +12.2M +22.2% Dec 31, 2018 10-Q 2019-02-13
Q3 2018 67.3M +12.3M +22.4% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 56.3M +1.31M +2.39% Jun 30, 2018 10-K 2019-09-27
Q1 2018 55.1M +82.8K +0.15% Mar 31, 2018 10-Q 2018-05-04
Q4 2017 55.1M +82.8K +0.15% Dec 31, 2017 10-Q 2018-02-09
Q3 2017 55M +6.8K +0.01% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 55M +6.8K +0.01% Jun 30, 2017 10-K 2018-09-26
Q1 2017 55M +6.8K +0.01% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 55M +3.87K +0.01% Dec 31, 2016 10-Q 2017-02-09
Q3 2016 55M -2.93K -0.01% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 55M +43.1K +0.08% Jun 30, 2016 10-K 2017-09-28
Q1 2016 55M +127K +0.23% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 55M +16.6M +43.2% Dec 31, 2015 10-Q 2016-02-09
Q3 2015 55M +130K +0.24% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 55M +266K +0.49% Jun 30, 2015 10-K 2016-09-09
Q1 2015 54.9M +702K +1.3% Mar 31, 2015 10-Q 2015-05-15
Q4 2014 38.4M 0 0% Dec 31, 2014 10-K 2016-09-09
Q3 2014 54.9M +16.5M +42.9% Sep 30, 2014 10-Q 2014-11-14
Q2 2014 54.7M +20.1M +58% Jun 30, 2014 10-K 2015-09-14
Q1 2014 54.2M +19.6M +56.5% Mar 31, 2014 10-Q 2014-05-15
Q4 2013 38.4M +3.81M +11% Dec 31, 2013 10-Q 2015-05-15
Q3 2013 38.4M +3.82M +11% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 34.6M +3.67M +11.9% Jun 30, 2013 10-K 2014-09-29
Q1 2013 34.6M +5.3M +18.1% Mar 31, 2013 10-Q 2013-05-15
Q4 2012 34.6M +5.3M +18.1% Dec 31, 2012 10-Q 2013-02-14
Q3 2012 34.6M +8.1M +30.6% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 31M +4.51M +17% Jun 30, 2012 10-K 2013-09-30
Q1 2012 29.3M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 29.3M Dec 31, 2011 10-Q 2012-02-14
Q3 2011 26.5M Sep 30, 2011 10-Q/A 2011-12-13
Q2 2011 26.4M Jun 30, 2011 10-K/A 2012-10-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.